Acute Effect of Exenatide on Brain Glucose Metabolism

NCT01588418 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Impaired Glucose Tolerance (IGT)
Diabetes

Interventions

DRUG: Exenatide
DRUG: Placebo

Sponsor

The University of Texas Health Science Center at San Antonio

Collaborators

[object Object]